Microbiology

  1. Natural SARS-CoV-2 infection in kept ferrets, Spain

    1. Christian Gortázar
    2. Sandra Barroso-Arévalo
    3. Elisa Ferreras-Colino
    4. Julio Isla
    5. Gabriela de la Fuente
    6. Belén Rivera
    7. Lucas Domínguez
    8. José de la Fuente
    9. José M. Sánchez-Vizcaíno

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Nasopharyngeal microbial communities of patients infected with SARS-COV-2 that developed COVID-19

    1. Maria Paz Ventero
    2. Rafael Ricardo Castro Cuadrat
    3. Inmaculada Vidal
    4. Bruno Gabriel N. Andrade
    5. Carmen Molina-Pardines
    6. Jose M. Haro-Moreno
    7. Felipe H. Coutinho
    8. Esperanza Merino
    9. Luciana CA Regitano
    10. Cynthia B Silveira
    11. Haithem Afli
    12. Mario López-Pérez
    13. Juan Carlos Rodríguez

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives

    1. Khanit Sa-ngiamsuntorn
    2. Ampa Suksatu
    3. Yongyut Pewkliang
    4. Piyanoot Thongsri
    5. Phongthon Kanjanasirirat
    6. Suwimon Manopwisedjaroen
    7. Sitthivut Charoensutthivarakul
    8. Patompon Wongtrakoongate
    9. Supaporn Pitiporn
    10. Phisit Khemawoot
    11. Somchai Chutipongtanate
    12. Suparerk Borwornpinyo
    13. Arunee Thitithanyanont
    14. Suradej Hongeng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A versatile reporter system to monitor virus infected cells and its application to dengue virus and SARS-CoV-2

    1. Felix Pahmeier
    2. Christoper J Neufeldt
    3. Berati Cerikan
    4. Vibhu Prasad
    5. Costantin Pape
    6. Vibor Laketa
    7. Alessia Ruggieri
    8. Ralf Bartenschlager
    9. Mirko Cortese

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Multi-site co-mutations and 5’UTR CpG immunity escape drive the evolution of SARS-CoV-2

    1. Jingsong Zhang
    2. Junyan Kang
    3. Mofang Liu
    4. Benhao Han
    5. Li Li
    6. Yongqun He
    7. Zhigang Yi
    8. Luonan Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles

    1. Maolin Lu
    2. Pradeep D. Uchil
    3. Wenwei Li
    4. Desheng Zheng
    5. Daniel S. Terry
    6. Jason Gorman
    7. Wei Shi
    8. Baoshan Zhang
    9. Tongqing Zhou
    10. Shilei Ding
    11. Romain Gasser
    12. Jérémie Prévost
    13. Guillaume Beaudoin-Bussières
    14. Sai Priya Anand
    15. Annemarie Laumaea
    16. Jonathan R. Grover
    17. Lihong Liu
    18. David D. Ho
    19. John R. Mascola
    20. Andrés Finzi
    21. Peter D. Kwong
    22. Scott C. Blanchard
    23. Walther Mothes

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferrets

    1. Magen E. Francis
    2. Brian Richardson
    3. Mara McNeil
    4. Melissa Rioux
    5. Mary K. Foley
    6. Anni Ge
    7. Roger D. Pechous
    8. Jason Kindrachuk
    9. Cheryl M. Cameron
    10. Christopher Richardson
    11. Jocelyne Lew
    12. Mark J. Cameron
    13. Volker Gerdts
    14. Darryl Falzarano
    15. Alyson A. Kelvin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Inhibitors of L-type calcium channels show therapeutic potential for treating SARS-CoV-2 infections by preventing virus entry and spread

    1. Marco R. Straus
    2. Miya K. Bidon
    3. Tiffany Tang
    4. Javier A. Jaimes
    5. Gary R. Whittaker
    6. Susan Daniel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2

    1. Laura N Jeffreys
    2. Shaun H Pennington
    3. Jack Duggan
    4. Claire H Caygill
    5. Rose C Lopeman
    6. Alastair F Breen
    7. Jessica B Jinks
    8. Alison Ardrey
    9. Samantha Donnellan
    10. Edward I Patterson
    11. Grant L Hughes
    12. David W Hong
    13. Paul M O’Neill
    14. Ghaith Aljayyoussi
    15. Andrew Owen
    16. Stephen A Ward
    17. Giancarlo A Biagini

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Ongoing Global and Regional Adaptive Evolution of SARS-CoV-2

    1. Nash D. Rochman
    2. Yuri I. Wolf
    3. Guilhem Faure
    4. Pascal Mutz
    5. Feng Zhang
    6. Eugene V. Koonin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 184 of 252 Next